|
 |
93 Optimal medical therapy in heart failure: is there space for additional heart rate control?
S Russell, M Oliver, H Rose, J Davies... - Heart, 2011 - Methods We performed a retrospective analysis from two HF clinics where patients are referred
for nurse lead, protocol-guided optimisation of conventional HF therapies. Data on patient demographics
and classification of HF including; severity (ejection fraction>35% vs ejection ...
Methods We performed a retrospective analysis from two HF clinics where patients are referred for nurse lead, protocol-guided optimisation of conventional HF therapies. Data on patient demographics and classification of HF including; severity (ejection fraction>35% vs ejection fraction≤35%), functional limitation (New York Heart Association; NYHA class), and cause (ischaemic vs non-ischaemic) were recorded. In addition, we collected data on patient's resting pulse (absolute value and rhythm: sinus vs atrial fibrillation), and blood pressure at the first and last clinic visits. Between the two clinic visits, patients underwent protocol-guided forced up-titration of standard neurohormonal HF therapies. We also collected data on the maximal tolerated doses of beta blocker (βB), ACE inhibitor (ACE-I) or angiotensin receptor blocker (ARB), and the reasons for the inability to achieve target doses of βB.
More Details:
93 Optimal medical therapy in heart failure: is there space for additional heart rate control? |
|
|
